Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 92 entries
Sorted by: Best Match Show Resources per page
Radiological and clinical predictors of scoliosis in patients with Chiari malformation type I and spinal cord syrinx from the Park-Reeves Syringomyelia Research Consortium.

Journal of neurosurgery. Pediatrics

Strahle JM, Taiwo R, Averill C, Torner J, Shannon CN, Bonfield CM, Tuite GF, Bethel-Anderson T, Rutlin J, Brockmeyer DL, Wellons JC, Leonard JR, Mangano FT, Johnston JM, Shah MN, Iskandar BJ, Tyler-Kabara EC, Daniels DJ, Jackson EM, Grant GA, Couture DE, Adelson PD, Alden TD, Aldana PR, Anderson RCE, Selden NR, Baird LC, Bierbrauer K, Chern JJ, Whitehead WE, Ellenbogen RG, Fuchs HE, Guillaume DJ, Hankinson TC, Iantosca MR, Oakes WJ, Keating RF, Khan NR, Muhlbauer MS, McComb JG, Menezes AH, Ragheb J, Smith JL, Maher CO, Greene S, Kelly M, O'Neill BR, Krieger MD, Tamber M, Durham SR, Olavarria G, Stone SSD, Kaufman BA, Heuer GG, Bauer DF, Albert G, Greenfield JP, Wait SD, Van Poppel MD, Eskandari R, Mapstone T, Shimony JS, Dacey RG, Smyth MD, Park TS, Limbrick DD.
PMID: 31419800
J Neurosurg Pediatr. 2019 Aug 16;1-8. doi: 10.3171/2019.5.PEDS18527. Epub 2019 Aug 16.

OBJECTIVE: Scoliosis is frequently a presenting sign of Chiari malformation type I (CM-I) with syrinx. The authors' goal was to define scoliosis in this population and describe how radiological characteristics of CM-I and syrinx relate to the presence and...

Cite
Strahle JM, Taiwo R, Averill C, et al. Radiological and clinical predictors of scoliosis in patients with Chiari malformation type I and spinal cord syrinx from the Park-Reeves Syringomyelia Research Consortium. J Neurosurg Pediatr. 2019;1-8doi: 10.3171/2019.5.PEDS18527.
Strahle, J. M., Taiwo, R., Averill, C., Torner, J., Shannon, C. N., Bonfield, C. M., Tuite, G. F., Bethel-Anderson, T., Rutlin, J., Brockmeyer, D. L., Wellons, J. C., Leonard, J. R., Mangano, F. T., Johnston, J. M., Shah, M. N., Iskandar, B. J., Tyler-Kabara, E. C., Daniels, D. J., Jackson, E. M., Grant, G. A., Couture, D. E., Adelson, P. D., Alden, T. D., Aldana, P. R., Anderson, R. C. E., Selden, N. R., Baird, L. C., Bierbrauer, K., Chern, J. J., Whitehead, W. E., Ellenbogen, R. G., Fuchs, H. E., Guillaume, D. J., Hankinson, T. C., Iantosca, M. R., Oakes, W. J., Keating, R. F., Khan, N. R., Muhlbauer, M. S., McComb, J. G., Menezes, A. H., Ragheb, J., Smith, J. L., Maher, C. O., Greene, S., Kelly, M., O'Neill, B. R., Krieger, M. D., Tamber, M., Durham, S. R., Olavarria, G., Stone, S. S. D., Kaufman, B. A., Heuer, G. G., Bauer, D. F., Albert, G., Greenfield, J. P., Wait, S. D., Van Poppel, M. D., Eskandari, R., Mapstone, T., Shimony, J. S., Dacey, R. G., Smyth, M. D., Park, T. S., & Limbrick, D. D. (2019). Radiological and clinical predictors of scoliosis in patients with Chiari malformation type I and spinal cord syrinx from the Park-Reeves Syringomyelia Research Consortium. Journal of neurosurgery. Pediatrics, 1-8. https://doi.org/10.3171/2019.5.PEDS18527
Strahle, Jennifer M, et al. "Radiological and clinical predictors of scoliosis in patients with Chiari malformation type I and spinal cord syrinx from the Park-Reeves Syringomyelia Research Consortium." Journal of neurosurgery. Pediatrics vol. (2019): 1-8. doi: https://doi.org/10.3171/2019.5.PEDS18527
Strahle JM, Taiwo R, Averill C, Torner J, Shannon CN, Bonfield CM, Tuite GF, Bethel-Anderson T, Rutlin J, Brockmeyer DL, Wellons JC, Leonard JR, Mangano FT, Johnston JM, Shah MN, Iskandar BJ, Tyler-Kabara EC, Daniels DJ, Jackson EM, Grant GA, Couture DE, Adelson PD, Alden TD, Aldana PR, Anderson RCE, Selden NR, Baird LC, Bierbrauer K, Chern JJ, Whitehead WE, Ellenbogen RG, Fuchs HE, Guillaume DJ, Hankinson TC, Iantosca MR, Oakes WJ, Keating RF, Khan NR, Muhlbauer MS, McComb JG, Menezes AH, Ragheb J, Smith JL, Maher CO, Greene S, Kelly M, O'Neill BR, Krieger MD, Tamber M, Durham SR, Olavarria G, Stone SSD, Kaufman BA, Heuer GG, Bauer DF, Albert G, Greenfield JP, Wait SD, Van Poppel MD, Eskandari R, Mapstone T, Shimony JS, Dacey RG, Smyth MD, Park TS, Limbrick DD. Radiological and clinical predictors of scoliosis in patients with Chiari malformation type I and spinal cord syrinx from the Park-Reeves Syringomyelia Research Consortium. J Neurosurg Pediatr. 2019 Aug 16;1-8. doi: 10.3171/2019.5.PEDS18527. Epub 2019 Aug 16. PMID: 31419800.
Copy Download .nbib Format: NLM
Corrigendum to: Can ARFI of the liver and spleen predict the presence of gastroesophageal varies? [Clin Radiol 73 (12) (2018) 1046-1051].

Clinical radiology

Wiles R, Patanwala I, Hankinson B, Healey P, Farrell C, Griffin C, Bonnett L, Richardson P.
PMID: 30538034
Clin Radiol. 2019 Feb;74(2):164. doi: 10.1016/j.crad.2018.11.006. Epub 2018 Dec 08.

No abstract available.

Cite
Wiles R, Patanwala I, Hankinson B, et al. Corrigendum to: Can ARFI of the liver and spleen predict the presence of gastroesophageal varies? [Clin Radiol 73 (12) (2018) 1046-1051]. Clin Radiol. 2018;74(2):164doi: 10.1016/j.crad.2018.11.006.
Wiles, R., Patanwala, I., Hankinson, B., Healey, P., Farrell, C., Griffin, C., Bonnett, L., & Richardson, P. (2019). Corrigendum to: Can ARFI of the liver and spleen predict the presence of gastroesophageal varies? [Clin Radiol 73 (12) (2018) 1046-1051]. Clinical radiology, 74(2), 164. https://doi.org/10.1016/j.crad.2018.11.006
Wiles, R, et al. "Corrigendum to: Can ARFI of the liver and spleen predict the presence of gastroesophageal varies? [Clin Radiol 73 (12) (2018) 1046-1051]." Clinical radiology vol. 74,2 (2019): 164. doi: https://doi.org/10.1016/j.crad.2018.11.006
Wiles R, Patanwala I, Hankinson B, Healey P, Farrell C, Griffin C, Bonnett L, Richardson P. Corrigendum to: Can ARFI of the liver and spleen predict the presence of gastroesophageal varies? [Clin Radiol 73 (12) (2018) 1046-1051]. Clin Radiol. 2019 Feb;74(2):164. doi: 10.1016/j.crad.2018.11.006. Epub 2018 Dec 08. PMID: 30538034.
Copy Download .nbib Format: NLM
Extradural decompression versus duraplasty in Chiari malformation type I with syrinx: outcomes on scoliosis from the Park-Reeves Syringomyelia Research Consortium.

Journal of neurosurgery. Pediatrics

Sadler B, Skidmore A, Gewirtz J, Anderson RCE, Haller G, Ackerman LL, Adelson PD, Ahmed R, Albert GW, Aldana PR, Alden TD, Averill C, Baird LC, Bauer DF, Bethel-Anderson T, Bierbrauer KS, Bonfield CM, Brockmeyer DL, Chern JJ, Couture DE, Daniels DJ, Dlouhy BJ, Durham SR, Ellenbogen RG, Eskandari R, Fuchs HE, George TM, Grant GA, Graupman PC, Greene S, Greenfield JP, Gross NL, Guillaume DJ, Hankinson TC, Heuer GG, Iantosca M, Iskandar BJ, Jackson EM, Jea AH, Johnston JM, Keating RF, Khan N, Krieger MD, Leonard JR, Maher CO, Mangano FT, Mapstone TB, McComb JG, McEvoy SD, Meehan T, Menezes AH, Muhlbauer M, Oakes WJ, Olavarria G, O'Neill BR, Ragheb J, Selden NR, Shah MN, Shannon CN, Smith J, Smyth MD, Stone SSD, Tuite GF, Wait SD, Wellons JC, Whitehead WE, Park TS, Limbrick DD, Strahle JM.
PMID: 34144521
J Neurosurg Pediatr. 2021 Jun 18;1-9. doi: 10.3171/2020.12.PEDS20552. Epub 2021 Jun 18.

OBJECTIVE: Scoliosis is common in patients with Chiari malformation type I (CM-I)-associated syringomyelia. While it is known that treatment with posterior fossa decompression (PFD) may reduce the progression of scoliosis, it is unknown if decompression with duraplasty is superior...

Cite
Sadler B, Skidmore A, Gewirtz J, et al. Extradural decompression versus duraplasty in Chiari malformation type I with syrinx: outcomes on scoliosis from the Park-Reeves Syringomyelia Research Consortium. J Neurosurg Pediatr. 2021;1-9doi: 10.3171/2020.12.PEDS20552.
Sadler, B., Skidmore, A., Gewirtz, J., Anderson, R. C. E., Haller, G., Ackerman, L. L., Adelson, P. D., Ahmed, R., Albert, G. W., Aldana, P. R., Alden, T. D., Averill, C., Baird, L. C., Bauer, D. F., Bethel-Anderson, T., Bierbrauer, K. S., Bonfield, C. M., Brockmeyer, D. L., Chern, J. J., Couture, D. E., Daniels, D. J., Dlouhy, B. J., Durham, S. R., Ellenbogen, R. G., Eskandari, R., Fuchs, H. E., George, T. M., Grant, G. A., Graupman, P. C., Greene, S., Greenfield, J. P., Gross, N. L., Guillaume, D. J., Hankinson, T. C., Heuer, G. G., Iantosca, M., Iskandar, B. J., Jackson, E. M., Jea, A. H., Johnston, J. M., Keating, R. F., Khan, N., Krieger, M. D., Leonard, J. R., Maher, C. O., Mangano, F. T., Mapstone, T. B., McComb, J. G., McEvoy, S. D., Meehan, T., Menezes, A. H., Muhlbauer, M., Oakes, W. J., Olavarria, G., O'Neill, B. R., Ragheb, J., Selden, N. R., Shah, M. N., Shannon, C. N., Smith, J., Smyth, M. D., Stone, S. S. D., Tuite, G. F., Wait, S. D., Wellons, J. C., Whitehead, W. E., Park, T. S., Limbrick, D. D., & Strahle, J. M. (2021). Extradural decompression versus duraplasty in Chiari malformation type I with syrinx: outcomes on scoliosis from the Park-Reeves Syringomyelia Research Consortium. Journal of neurosurgery. Pediatrics, 1-9. https://doi.org/10.3171/2020.12.PEDS20552
Sadler, Brooke, et al. "Extradural decompression versus duraplasty in Chiari malformation type I with syrinx: outcomes on scoliosis from the Park-Reeves Syringomyelia Research Consortium." Journal of neurosurgery. Pediatrics vol. (2021): 1-9. doi: https://doi.org/10.3171/2020.12.PEDS20552
Sadler B, Skidmore A, Gewirtz J, Anderson RCE, Haller G, Ackerman LL, Adelson PD, Ahmed R, Albert GW, Aldana PR, Alden TD, Averill C, Baird LC, Bauer DF, Bethel-Anderson T, Bierbrauer KS, Bonfield CM, Brockmeyer DL, Chern JJ, Couture DE, Daniels DJ, Dlouhy BJ, Durham SR, Ellenbogen RG, Eskandari R, Fuchs HE, George TM, Grant GA, Graupman PC, Greene S, Greenfield JP, Gross NL, Guillaume DJ, Hankinson TC, Heuer GG, Iantosca M, Iskandar BJ, Jackson EM, Jea AH, Johnston JM, Keating RF, Khan N, Krieger MD, Leonard JR, Maher CO, Mangano FT, Mapstone TB, McComb JG, McEvoy SD, Meehan T, Menezes AH, Muhlbauer M, Oakes WJ, Olavarria G, O'Neill BR, Ragheb J, Selden NR, Shah MN, Shannon CN, Smith J, Smyth MD, Stone SSD, Tuite GF, Wait SD, Wellons JC, Whitehead WE, Park TS, Limbrick DD, Strahle JM. Extradural decompression versus duraplasty in Chiari malformation type I with syrinx: outcomes on scoliosis from the Park-Reeves Syringomyelia Research Consortium. J Neurosurg Pediatr. 2021 Jun 18;1-9. doi: 10.3171/2020.12.PEDS20552. Epub 2021 Jun 18. PMID: 34144521.
Copy Download .nbib Format: NLM
Prolactin and Risk of Epithelial Ovarian Cancer.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Hathaway CA, Rice MS, Townsend MK, Hankinson SE, Arslan AA, Buring JE, Hallmans G, Idahl A, Kubzansky LD, Lee IM, Lundin EA, Sluss PM, Zeleniuch-Jacquotte A, Tworoger SS.
PMID: 34244157
Cancer Epidemiol Biomarkers Prev. 2021 Sep;30(9):1652-1659. doi: 10.1158/1055-9965.EPI-21-0139. Epub 2021 Jul 08.

BACKGROUND: Prolactin is synthesized in the ovaries and may play a role in ovarian cancer etiology. One prior prospective study observed a suggestive positive association between prolactin levels and risk of ovarian cancer.METHODS: We conducted a pooled case-control study...

Cite
Hathaway CA, Rice MS, Townsend MK, et al. Prolactin and Risk of Epithelial Ovarian Cancer. Cancer Epidemiol Biomarkers Prev. 2021;30(9):1652-1659doi: 10.1158/1055-9965.EPI-21-0139.
Hathaway, C. A., Rice, M. S., Townsend, M. K., Hankinson, S. E., Arslan, A. A., Buring, J. E., Hallmans, G., Idahl, A., Kubzansky, L. D., Lee, I. M., Lundin, E. A., Sluss, P. M., Zeleniuch-Jacquotte, A., & Tworoger, S. S. (2021). Prolactin and Risk of Epithelial Ovarian Cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 30(9), 1652-1659. https://doi.org/10.1158/1055-9965.EPI-21-0139
Hathaway, Cassandra A, et al. "Prolactin and Risk of Epithelial Ovarian Cancer." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology vol. 30,9 (2021): 1652-1659. doi: https://doi.org/10.1158/1055-9965.EPI-21-0139
Hathaway CA, Rice MS, Townsend MK, Hankinson SE, Arslan AA, Buring JE, Hallmans G, Idahl A, Kubzansky LD, Lee IM, Lundin EA, Sluss PM, Zeleniuch-Jacquotte A, Tworoger SS. Prolactin and Risk of Epithelial Ovarian Cancer. Cancer Epidemiol Biomarkers Prev. 2021 Sep;30(9):1652-1659. doi: 10.1158/1055-9965.EPI-21-0139. Epub 2021 Jul 08. PMID: 34244157; PMCID: PMC8419083.
Copy Download .nbib Format: NLM
Primate selfies and anthropozoonotic diseases: lack of rule compliance and poor risk perception threatens orangutans.

Folia primatologica; international journal of primatology

Molyneaux A, Hankinson E, Kaban M, Svensson MS, Cheyne SM, Nijman V.
PMID: 34695831
Folia Primatol (Basel). 2021 Oct 25; doi: 10.1159/000520371. Epub 2021 Oct 25.

Our understanding of the transmission of anthropozoonotic diseases between humans and nonhuman primates, particularly great apes due to their close genetic relationship with humans, highlights a serious potential threat to the survival of these species. This is particularly the...

Cite
Molyneaux A, Hankinson E, Kaban M, et al. Primate selfies and anthropozoonotic diseases: lack of rule compliance and poor risk perception threatens orangutans. Folia Primatol (Basel). 2021;doi: 10.1159/000520371.
Molyneaux, A., Hankinson, E., Kaban, M., Svensson, M. S., Cheyne, S. M., & Nijman, V. (2021). Primate selfies and anthropozoonotic diseases: lack of rule compliance and poor risk perception threatens orangutans. Folia primatologica; international journal of primatology, . https://doi.org/10.1159/000520371
Molyneaux, Andrea, et al. "Primate selfies and anthropozoonotic diseases: lack of rule compliance and poor risk perception threatens orangutans." Folia primatologica; international journal of primatology vol. (2021). doi: https://doi.org/10.1159/000520371
Molyneaux A, Hankinson E, Kaban M, Svensson MS, Cheyne SM, Nijman V. Primate selfies and anthropozoonotic diseases: lack of rule compliance and poor risk perception threatens orangutans. Folia Primatol (Basel). 2021 Oct 25; doi: 10.1159/000520371. Epub 2021 Oct 25. PMID: 34695831.
Copy Download .nbib Format: NLM
Central Adiposity and Subsequent Risk of Breast Cancer by Menopause Status.

Journal of the National Cancer Institute

Houghton SC, Eliassen H, Tamimi RM, Willett WC, Rosner BA, Hankinson SE.
PMID: 33367714
J Natl Cancer Inst. 2021 Jul 01;113(7):900-908. doi: 10.1093/jnci/djaa197.

BACKGROUND: Increased body mass index (BMI) is associated with higher postmenopausal breast cancer risk and lower premenopausal breast cancer risk. Less is known about the central adiposity-breast cancer risk association, particularly for tumor subtypes.METHODS: We used prospective waist (WC)...

Cite
Houghton SC, Eliassen H, Tamimi RM, et al. Central Adiposity and Subsequent Risk of Breast Cancer by Menopause Status. J Natl Cancer Inst. 2021;113(7):900-908doi: 10.1093/jnci/djaa197.
Houghton, S. C., Eliassen, H., Tamimi, R. M., Willett, W. C., Rosner, B. A., & Hankinson, S. E. (2021). Central Adiposity and Subsequent Risk of Breast Cancer by Menopause Status. Journal of the National Cancer Institute, 113(7), 900-908. https://doi.org/10.1093/jnci/djaa197
Houghton, Serena C, et al. "Central Adiposity and Subsequent Risk of Breast Cancer by Menopause Status." Journal of the National Cancer Institute vol. 113,7 (2021): 900-908. doi: https://doi.org/10.1093/jnci/djaa197
Houghton SC, Eliassen H, Tamimi RM, Willett WC, Rosner BA, Hankinson SE. Central Adiposity and Subsequent Risk of Breast Cancer by Menopause Status. J Natl Cancer Inst. 2021 Jul 01;113(7):900-908. doi: 10.1093/jnci/djaa197. PMID: 33367714; PMCID: PMC8491796.
Copy Download .nbib Format: NLM
Birthweight and subsequent risk for thyroid and autoimmune conditions in postmenopausal women.

Journal of developmental origins of health and disease

Monahan B, Farland LV, Shadyab AH, Hankinson SE, Manson JE, Spracklen CN.
PMID: 34658316
J Dev Orig Health Dis. 2021 Oct 18;1-8. doi: 10.1017/S204017442100057X. Epub 2021 Oct 18.

The objective of this study was to determine the association between birthweight and risk of thyroid and autoimmune conditions in a large sample of postmenopausal women. Baseline data from the Women's Health Initiative (n = 80,806) were used to...

Cite
Monahan B, Farland LV, Shadyab AH, et al. Birthweight and subsequent risk for thyroid and autoimmune conditions in postmenopausal women. J Dev Orig Health Dis. 2021;1-8doi: 10.1017/S204017442100057X.
Monahan, B., Farland, L. V., Shadyab, A. H., Hankinson, S. E., Manson, J. E., & Spracklen, C. N. (2021). Birthweight and subsequent risk for thyroid and autoimmune conditions in postmenopausal women. Journal of developmental origins of health and disease, 1-8. https://doi.org/10.1017/S204017442100057X
Monahan, Brian, et al. "Birthweight and subsequent risk for thyroid and autoimmune conditions in postmenopausal women." Journal of developmental origins of health and disease vol. (2021): 1-8. doi: https://doi.org/10.1017/S204017442100057X
Monahan B, Farland LV, Shadyab AH, Hankinson SE, Manson JE, Spracklen CN. Birthweight and subsequent risk for thyroid and autoimmune conditions in postmenopausal women. J Dev Orig Health Dis. 2021 Oct 18;1-8. doi: 10.1017/S204017442100057X. Epub 2021 Oct 18. PMID: 34658316.
Copy Download .nbib Format: NLM
Neoplastic and immune single cell transcriptomics define subgroup-specific intra-tumoral heterogeneity of childhood medulloblastoma.

Neuro-oncology

Riemondy KA, Venkataraman S, Willard N, Nellan A, Sanford B, Griesinger AM, Amani V, Mitra S, Hankinson TC, Handler MH, Sill M, Ocasio J, Weir SJ, Malawsky DS, Gershon TR, Garancher A, Wechsler-Reya RJ, Hesselberth JR, Foreman NK, Donson AM, Vibhakar R.
PMID: 34077540
Neuro Oncol. 2021 Jun 02; doi: 10.1093/neuonc/noab135. Epub 2021 Jun 02.

BACKGROUND: Medulloblastoma (MB) is a heterogeneous disease in which neoplastic cells and associated immune cells contribute to disease progression. We aimed to determine the influence of neoplastic and immune cell diversity on MB biology in patient samples and animal...

Cite
Riemondy KA, Venkataraman S, Willard N, et al. Neoplastic and immune single cell transcriptomics define subgroup-specific intra-tumoral heterogeneity of childhood medulloblastoma. Neuro Oncol. 2021;doi: 10.1093/neuonc/noab135.
Riemondy, K. A., Venkataraman, S., Willard, N., Nellan, A., Sanford, B., Griesinger, A. M., Amani, V., Mitra, S., Hankinson, T. C., Handler, M. H., Sill, M., Ocasio, J., Weir, S. J., Malawsky, D. S., Gershon, T. R., Garancher, A., Wechsler-Reya, R. J., Hesselberth, J. R., Foreman, N. K., Donson, A. M., & Vibhakar, R. (2021). Neoplastic and immune single cell transcriptomics define subgroup-specific intra-tumoral heterogeneity of childhood medulloblastoma. Neuro-oncology, . https://doi.org/10.1093/neuonc/noab135
Riemondy, Kent A, et al. "Neoplastic and immune single cell transcriptomics define subgroup-specific intra-tumoral heterogeneity of childhood medulloblastoma." Neuro-oncology vol. (2021). doi: https://doi.org/10.1093/neuonc/noab135
Riemondy KA, Venkataraman S, Willard N, Nellan A, Sanford B, Griesinger AM, Amani V, Mitra S, Hankinson TC, Handler MH, Sill M, Ocasio J, Weir SJ, Malawsky DS, Gershon TR, Garancher A, Wechsler-Reya RJ, Hesselberth JR, Foreman NK, Donson AM, Vibhakar R. Neoplastic and immune single cell transcriptomics define subgroup-specific intra-tumoral heterogeneity of childhood medulloblastoma. Neuro Oncol. 2021 Jun 02; doi: 10.1093/neuonc/noab135. Epub 2021 Jun 02. PMID: 34077540.
Copy Download .nbib Format: NLM
[No title available]

Molecular pharmacology

Carlson EJ, Georg GI, Hawkinson JE.
PMID: 34718225
Mol Pharmacol. 2021 Oct 30; doi: 10.1124/molpharm.121.000349. Epub 2021 Oct 30.

The

Cite
Carlson EJ, Georg GI, Hawkinson JE. . Mol Pharmacol. 2021;doi: 10.1124/molpharm.121.000349.
Carlson, E. J., Georg, G. I., & Hawkinson, J. E. (2021). . Molecular pharmacology, . https://doi.org/10.1124/molpharm.121.000349
Carlson, Erick J, et al. "." Molecular pharmacology vol. (2021). doi: https://doi.org/10.1124/molpharm.121.000349
Carlson EJ, Georg GI, Hawkinson JE. . Mol Pharmacol. 2021 Oct 30; doi: 10.1124/molpharm.121.000349. Epub 2021 Oct 30. PMID: 34718225.
Copy Download .nbib Format: NLM
Predictors of fast and ultrafast shunt failure in pediatric hydrocephalus: a Hydrocephalus Clinical Research Network study.

Journal of neurosurgery. Pediatrics

Hauptman JS, Kestle J, Riva-Cambrin J, Kulkarni AV, Browd SR, Rozzelle CJ, Whitehead WE, Naftel RP, Pindrik J, Limbrick DD, Drake J, Wellons JC, Tamber MS, Shannon CN, Simon TD, Pollack IF, McDonald PJ, Krieger MD, Chu J, Hankinson TC, Jackson EM, Alvey JS, Reeder RW, Holubkov R.
PMID: 33338993
J Neurosurg Pediatr. 2020 Dec 18;1-10. doi: 10.3171/2020.7.PEDS20111. Epub 2020 Dec 18.

OBJECTIVE: The primary objective of this study was to use the prospective Hydrocephalus Clinical Research Network (HCRN) registry to determine clinical predictors of fast time to shunt failure (≤ 30 days from last revision) and ultrafast time to failure...

Cite
Hauptman JS, Kestle J, Riva-Cambrin J, et al. Predictors of fast and ultrafast shunt failure in pediatric hydrocephalus: a Hydrocephalus Clinical Research Network study. J Neurosurg Pediatr. 2020;1-10doi: 10.3171/2020.7.PEDS20111.
Hauptman, J. S., Kestle, J., Riva-Cambrin, J., Kulkarni, A. V., Browd, S. R., Rozzelle, C. J., Whitehead, W. E., Naftel, R. P., Pindrik, J., Limbrick, D. D., Drake, J., Wellons, J. C., Tamber, M. S., Shannon, C. N., Simon, T. D., Pollack, I. F., McDonald, P. J., Krieger, M. D., Chu, J., Hankinson, T. C., Jackson, E. M., Alvey, J. S., Reeder, R. W., Holubkov, R. (2020). Predictors of fast and ultrafast shunt failure in pediatric hydrocephalus: a Hydrocephalus Clinical Research Network study. Journal of neurosurgery. Pediatrics, 1-10. https://doi.org/10.3171/2020.7.PEDS20111
Hauptman, Jason S, et al. "Predictors of fast and ultrafast shunt failure in pediatric hydrocephalus: a Hydrocephalus Clinical Research Network study." Journal of neurosurgery. Pediatrics vol. (2020): 1-10. doi: https://doi.org/10.3171/2020.7.PEDS20111
Hauptman JS, Kestle J, Riva-Cambrin J, Kulkarni AV, Browd SR, Rozzelle CJ, Whitehead WE, Naftel RP, Pindrik J, Limbrick DD, Drake J, Wellons JC, Tamber MS, Shannon CN, Simon TD, Pollack IF, McDonald PJ, Krieger MD, Chu J, Hankinson TC, Jackson EM, Alvey JS, Reeder RW, Holubkov R. Predictors of fast and ultrafast shunt failure in pediatric hydrocephalus: a Hydrocephalus Clinical Research Network study. J Neurosurg Pediatr. 2020 Dec 18;1-10. doi: 10.3171/2020.7.PEDS20111. Epub 2020 Dec 18. PMID: 33338993.
Copy Download .nbib Format: NLM
Interrater reliability of a method to assess hypothalamic involvement in pediatric adamantinomatous craniopharyngioma.

Journal of neurosurgery. Pediatrics

Whelan R, Prince E, Mirsky DM, Naftel R, Bhatia A, Pettorini B, Avula S, Staulcup S, Alexander AL, Meier M, Hankinson TC.
PMID: 31604324
J Neurosurg Pediatr. 2019 Oct 11;1-6. doi: 10.3171/2019.8.PEDS19295. Epub 2019 Oct 11.

OBJECTIVE: Pediatric adamantinomatous craniopharyngiomas (ACPs) are histologically benign brain tumors that confer significant neuroendocrine morbidity. Previous studies have demonstrated that injury to the hypothalamus is associated with worsened quality of life and a shorter lifespan. This insight helps many...

Cite
Whelan R, Prince E, Mirsky DM, et al. Interrater reliability of a method to assess hypothalamic involvement in pediatric adamantinomatous craniopharyngioma. J Neurosurg Pediatr. 2019;1-6doi: 10.3171/2019.8.PEDS19295.
Whelan, R., Prince, E., Mirsky, D. M., Naftel, R., Bhatia, A., Pettorini, B., Avula, S., Staulcup, S., Alexander, A. L., Meier, M., & Hankinson, T. C. (2019). Interrater reliability of a method to assess hypothalamic involvement in pediatric adamantinomatous craniopharyngioma. Journal of neurosurgery. Pediatrics, 1-6. https://doi.org/10.3171/2019.8.PEDS19295
Whelan, Ros, et al. "Interrater reliability of a method to assess hypothalamic involvement in pediatric adamantinomatous craniopharyngioma." Journal of neurosurgery. Pediatrics vol. (2019): 1-6. doi: https://doi.org/10.3171/2019.8.PEDS19295
Whelan R, Prince E, Mirsky DM, Naftel R, Bhatia A, Pettorini B, Avula S, Staulcup S, Alexander AL, Meier M, Hankinson TC. Interrater reliability of a method to assess hypothalamic involvement in pediatric adamantinomatous craniopharyngioma. J Neurosurg Pediatr. 2019 Oct 11;1-6. doi: 10.3171/2019.8.PEDS19295. Epub 2019 Oct 11. PMID: 31604324.
Copy Download .nbib Format: NLM
Androgen receptor expression in normal breast tissue and subsequent breast cancer risk.

NPJ breast cancer

Kensler KH, Beca F, Baker GM, Heng YJ, Beck AH, Schnitt SJ, Hazra A, Rosner BA, Eliassen AH, Hankinson SE, Brown M, Tamimi RM.
PMID: 30276234
NPJ Breast Cancer. 2018 Sep 21;4:33. doi: 10.1038/s41523-018-0085-3. eCollection 2018.

Sex steroid hormone signaling is critical in the development of breast cancers, although the role of the androgen receptor remains unclear. This study evaluated androgen receptor (AR) expression in normal breast tissue as a potential marker of breast cancer...

Cite
Kensler KH, Beca F, Baker GM, et al. Androgen receptor expression in normal breast tissue and subsequent breast cancer risk. NPJ Breast Cancer. 2018;4:33doi: 10.1038/s41523-018-0085-3.
Kensler, K. H., Beca, F., Baker, G. M., Heng, Y. J., Beck, A. H., Schnitt, S. J., Hazra, A., Rosner, B. A., Eliassen, A. H., Hankinson, S. E., Brown, M., & Tamimi, R. M. (2018). Androgen receptor expression in normal breast tissue and subsequent breast cancer risk. NPJ breast cancer, 433. https://doi.org/10.1038/s41523-018-0085-3
Kensler, Kevin H, et al. "Androgen receptor expression in normal breast tissue and subsequent breast cancer risk." NPJ breast cancer vol. 4 (2018): 33. doi: https://doi.org/10.1038/s41523-018-0085-3
Kensler KH, Beca F, Baker GM, Heng YJ, Beck AH, Schnitt SJ, Hazra A, Rosner BA, Eliassen AH, Hankinson SE, Brown M, Tamimi RM. Androgen receptor expression in normal breast tissue and subsequent breast cancer risk. NPJ Breast Cancer. 2018 Sep 21;4:33. doi: 10.1038/s41523-018-0085-3. eCollection 2018. PMID: 30276234; PMCID: PMC6155011.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 92 entries